CBD is one of over 60 compounds found in cannabis that belong to a class of ingredients called cannabinoids. Until recently, THC (tetrahydrocannabinol) was getting most of the attention because it’s the ingredient in cannabis that produces intoxicating effects in users. But CBD is also present in high concentrations — and the world is awakening to its possible benefits.
‘The media has no doubt helped drive this popularity,’ says Dr Sarah Brewer, medical director at Healthspan. ‘However, the main drive is because people who take it experience the benefits very quickly, and “word of mouth” is a powerful thing. CBD oil also has such a wide range of benefits, reducing anxiety, promoting relaxation, ensuring a good night’s sleep, reducing pain perception and improving general feelings of wellbeing. It therefore appeals to a wide range of people.’
But it also requires careful research before making a purchase. Because the cannabis plant readily absorbs pesticides, heavy metals and other chemicals that are in the soil and water, it’s so important that cannabis plants are frequently tested while they are growing. And it’s up to manufactures to test CBD products, too. When you are shopping for CBD oil, look for products that have been tested for contaminants and for CBD vs. THC levels.
Thankfully this doesn’t apply to me personally, but studies have shown that CBD oil can be very beneficial to those who suffer from Diabetes. It does this by decreasing insulin resistance. The exact science behind this is still being researched, but some scientists believe that it is related to a cannabinoid called THCV, which has been shown to increase insulin sensitivity.
If you haven’t been bombarded with CBD marketing or raves about it from friends, get ready. This extract—which comes from either marijuana or its industrial cousin, hemp—is popping up everywhere. There are CBD capsules, tinctures, and liquids for vaping plus CBD-infused lotions, beauty products, snacks, coffee, and even vaginal suppositories. Already some 1,000 brands of CBD products are available in stores—and online in states that don’t have lenient cannabis laws. This is a tiny fraction of what’s to come: The CBD market is poised to exceed $22 billion by 2022, per the Chicago-based research firm Brightfield Group.
More recent experiments, involving the administration of a part CBD part THC solution, have yielded results that contradict the first supposition. At present, on the evidence that cannabidiol reduces some of the psychoactive effects of tetrahydrocannabinol (acting as a de facto antidepressant), scientists argue that cannabidiol has a holistic but indirect influence on all cannabinoid receptors in the endocannabinoid system. The main consequence of this impact seems to be an increase in the production of endocannabinoids. This is now the prevailing idea that accounts for the mountains of empirical evidence of how the benefits of cannabidiol are expressed at the cellular level.